OTHER × Carcinoma, Ovarian Epithelial × liposomal doxorubicin × Clear all Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Phase 1 Completed
18 enrolled
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
Phase 4 Unknown
396 enrolled
CLIO
Phase 2 Unknown
160 enrolled
Trientine
Phase 1/2 Completed
18 enrolled 16 charts
A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer
Phase 1 Completed
21 enrolled
Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase 1/2 Terminated
15 enrolled 12 charts
Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)
Phase NA Completed
8 enrolled
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Phase 1 Terminated
1 enrolled
PaLiDo
Phase 2 Completed
33 enrolled
Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma
Phase 2 Terminated
15 enrolled 10 charts
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
Phase 1/2 Completed
107 enrolled